CollPlant Biotechnologies Ltd.
CLGNNASDAQ
Healthcare
Biotechnology
$0.49
-0.04(-8.2%)
52W $0.53 – $4.54
CollPlant Biotechnologies Ltd.
Revenue breakdown: Revenues From Milestones (86.7%), Revenues From Sales Of Goods (13.3%).
$6MMkt Cap
$2MRev TTM
-$12MNI TTM
-0.6xP/E TTM
Latest Earnings
20-F
FY FY2025Mar 25, 2026CollPlant Biotechnologies Ltd. reported $2.4 million in revenue for FY 2025, a significant increase from $0.5 million in FY 2024, driven primarily by a $2.0 million milestone payment from AbbVie under the dermal filler development agreement. The company incurred a net loss of $11.5 million, widening slightly from $11.49 million in FY 2024 (per document text) but consistent with XBRL’s...
Fundamentals
How The Business Makes Money
Revenue by Segment
Revenues From Milestones86.7%
Revenues From Sales Of Goods13.3%
Revenue by Geography
US97.5%
CA1.3%
Europe And Other0.9%
IL0.3%
Company Profile
CIK0001631487
ISINIL0004960188
CUSIP19516R107
Phone972 73 232 5600
AddressWeizmann Science Park, Rehovot, 7670104, IL
SEC EDGAR